Notably, the effect of SIRT7 on PD-L1 expression in melanoma cells under non-stressed conditions is negligible, indicating that, in this malignancy, SIRT7 governs PD-L1 expression through distinct cancer-cell-type-specific regulatory circuits shaped by microenvironmental cues [44]. The gene discussed is SIRT7; the disease is melanoma.